Trial intelligence / Profile preview

Late vs early follicular phase initiation of ovarian stimulation with Bemfola in oocyte donors

2017-005005-12Phase 3Completed

Sponsor
UZ Brussel
Start
May 2018
Modality
Recombinant Proteins and Enzymes
Countries
1
01

Overview

Phase 3, randomised trial of recombinant human follicle stimulating hormone in female infertility (2 arms), sponsored by UZ Brussel. Primary endpoint: Total number of mature oocytes (COC) retrieved. Started May 2018; status: completed.

02

Drugs

recombinant human follicle stimulating hormone
03

Conditions

female infertility

Beyond the preview

Go deeper on 2017-005005-12.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2017-005005-12.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call